Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry by agreeing to ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement.

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with ...

Newly disclosed agreements show that lower U.S. drug prices were only one side of the bargain. Pfizer and Eli Lilly also received tariff protection and other commitments, while extensive redactions ...

Pfizer CEO Albert Bourla (L) speaks in the White House as Medicare and Medicaid Administrator Mehmet Oz and US President Donald Trump look on during an announcement ...

The Trump administration's efforts to lower drug prices included promised changes to Medicaid. But it's still unclear which drugs will be affected. And each state has to opt in.

To avoid triggering massive U.S. price cuts, pharmaceutical companies now incentivized to protect their larger U.S. profits by raising prices elsewhere, drug policy experts say.

In a surprising turnaround, Pfizer said Tuesday that it will defer raising prices on multiple drugs after heavy pressure from President Donald Trump. The pharmaceutical company’s announcement came ...